City of Hope Medical Center
Duarte, California, 91010, United States
Location status: Recruiting
NCT Number: NCT07186192
The overall purpose of this randomized control trial (RCT) is to determine the clinical effect of a multilevel, RPM-enhanced intervention during and after completion of outpatient CAR-T therapy in 190 patients and their family caregivers (FCGs).
Interested in participating?
Request Info18 year and older
All sexes
Interventional
Phase 3
Duarte, California, 91010, United States
Location status: Recruiting
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Patient Inclusion Criteria Informed Consent and Willingness to Participate
Family Caregiver Inclusion Criteria Informed Consent and Willingness to Participate
Exclusion criteria
1. An employee who is under the direct/indirect supervision of the PI/ a co-investigator/ the study manager 2. A direct study team member
-
Patients and family caregivers that are randomized into the intervetnion arm (Digital health intervention) will receive a 90 day nurse-drive, digital health intervention. Participate in self-management coaching sessions
Other names: Education for Intervention, Intervention by Education, Intervention through Education, Intervention, Educational
Wear a FitBit device and use a mobile app for nurse tracking
Ancillary studies
Given usual care
Other names: best practice, standard of care, standard of care, standard of care, standard therapy
Time frame: Baseline, Day 15 - Day 20 post-CAR-T, Day 30, Day 60, and Day 90
This is validated measure of 22 CAR-T specific symptoms and other cancer-related symptoms. Symptom severity is rated on a 10-point scale: 1-3 mild, 4-6 moderate, ≥7 severe. Patients also rate how much their symptoms interfere with 6 functional domains: walking, activity, working/housework, relationships, enjoyment of life, and mood. A change in 1.2 points is clinically meaningful and cutoffs for clinical deficits have been defined. Cronbach's α reliability: 82-0.94.
Time frame: Baseline, Day 15 - Day 20 post-CAR-T, Day 30, Day 60, and Day 90
This is an efficient, low-subject-burden measure to evaluate psychological distress over the past week, based on a scale of 0 (no distress) to 10 (extremely distressed). A cut-off of 3/10 indicates a need for intervention, with acceptable sensitivity (94.1%) and specificity (71.2%) compared to the longer Hospital Anxiety and Depression Scale (HADS). The DT has been validated in FCGs, and we chose it for its brevity, accuracy ease of use in remote monitoring, and validity in FCGs.
Time frame: Baseline, Day 30, Day 60, and Day 90
This is a 14-item tool designed to measure the impact of caregiving on three dimensions of burden: objective, subjective demand, and subjective stress. Internal consistency for the three dimensions ranges from 0.81-0.90. The ordinal scale ranges from 1-5 (a lot less to a lot more). The following cutoff scores are interpreted as high burden: 1) a score of ≥23 for objective burden, 2) a score of ≥15 for subjective demand, and 3) a score of ≥13.5 for subjective stress.
Time frame: Baseline, Day 30, Day 60, and Day 90
This is a cancer-specific version of the FACIT (Functional Assessment of Chronic Illness Therapy) Measurement System. It contains a 27-item compilation of general questions divided into four QoL domains: Physical Well-Being, Social/Family Well-Being, Emotional Well-Being, and Functional Well-Being. For each item, the respondent indicates on a 5-point Likert scale (0=not at all; 4=very much) how true each statement is for him/her during the past 7d. The FACT-G yields a total score for overall QoL as well as subscale scores. Internal consistency and reliability measures revealed a Cronbach's α of 0.89 for the total FACT-G, and a range of 0.70-0.82 for the four subscales.
Time frame: Baseline, Day 30, Day 60, and Day 90
This is a 37-item instrument that measures FCG QoL in the physical, psychological, social, and spiritual well-being domains. Ordinal scale ranges from 0-10, with higher scores indicating better QoL. The instrument was revised and tested from 1994-1998 in a study of 219 FCGs of cancer patients. The test-retest reliability was r=0.89 and internal consistency was α r=0.69.
Time frame: Baseline, Day 30, Day 60, and Day 90
This is a 4-item scale designed to assess marital satisfaction for couples married or in a committed relationship. This instrument measures patient/FCG consensus, satisfaction, affectional expression and cohesion that directly assess general communication between couples. Alpha coefficients have been reported from 0.92 to 0.95. The measure will be included as a covariate for analysis. will be used to assess marital satisfaction (Patient, FCG).
Time frame: Baseline, Day 30, Day 60, and Day 90
This is a 10-item survey designed to assess FCG's level of engagement and preparedness to care for patients during care transitions. Psychometric assessment was conducted in two randomly equivalent waves of participants (N=434), including FCGs of patients with cancer and/or chronic lung disease. The estimated person-separation reliability was 0.84.
Time frame: Baseline, Day 30, Day 60, and Day 90
This is a measure of patient "activation", which uses a Guttman-like scale that reflects patient level of engagement and empowerment in their healthcare. Cronbach's α from our pilot study was 0.92.
Time frame: Baseline, Day 30, Day 60, and Day 90
This is a brief, 8-item questionnaire used to assess an individual's confidence in their ability to manage specific aspects of symptoms. Specifically, the tool measures confidence in managing symptoms during daily activities, social interactions, and in public places.
Time frame: Baseline, Day 30, Day 60, and Day 90
This is a modified version of the Self-Efficacy Scale. Contains 8 items that assess FCG perceived confidence in self-management. Uses a 4-point Likert scale; higher scores represent greater confidence. Cronbach's α from our pilot: 0.89.
Time frame: Baseline
This is a questionnaire to assess patient demographics.
Time frame: Baseline
This is a questionnaire to assess patient demographics.
Time frame: Patients: Day 90 only; CAR-T clinical care team: before intervention starts and after intervention ends
This is a questionnaire used to assess patient, family caregiver, and CAR-T clinical care team on acceptability of the intervention.
Time frame: Patients: Day 90 only; CAR-T clinical care team: before intervention starts and after intervention ends
This is a questionnaire used to assess patient, family caregiver, and CAR-T clinical care team on the appropriateness of the intervention.
Time frame: Patients: Day 90 only; CAR-T clinical care team: before intervention starts and after intervention ends
This is a questionnaire used to assess patient, family caregiver, and CAR-T clinical care team on the feasibility of the intervention.
Contact information is provided by the study sponsor or research team.
City of Hope Medical Center
Other
Digital Health Intervention for Self-Management and Telemonitoring in Chimeric Antigen Receptor-T Cell (CAR-T)Therapy
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05724121
Arrhythmias, Cardiac, Atrial Fibrillation
Bethesda, Maryland, United States
View Trial DetailsNCT03486873
Hematologic Diseases, Hematologic Malignancies
Tucson, Arizona, United States
View Trial DetailsNCT07285668
Hematologic Diseases, Hematologic Malignancies
Madison, Wisconsin, United States
View Trial DetailsNCT04728893
Blood Protein Disorders, Cardiovascular Diseases
Springdale, Arkansas, United States
View Trial Details